Training and Resources

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

KEYTRUDA® (pembrolizumab) in adjuvant renal cell carcinoma (RCC)

RCC Pre-Operative Considerations & Post-Operative MDT Decision Aid

GB-RCC-00497 | Date of Preparation: November 2022

Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]

KEYNOTE-564 slide deck

GB-RCC-00698 | Date of Preparation: October 2023

Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]

Adjuvant RCC patient identification guide

GB-RCC-00489 | Date of Preparation: October 2022

Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]

For more information about KEYTRUDA in adjuvant RCC:

KEYTRUDA in advanced renal cell carcinoma (aRCC)

Patient assets

To order printed versions of these diaries to your place of work, please contact msdukoncology@msd.com.

Please be aware you should not direct your patient to this website. You should download this diary on their behalf and share it with them as appropriate.

HCP treatment optimisation guide

For more information about KEYTRUDA in advanced RCC:

Supporting documentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) 
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website